Rate of M-component changes and clinical course of 23 responsive myeloma patients.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy* / Q000401:mortality / Q000652:urine; D010440:Peptichemio / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D007136:Immunoglobulins; D014750:Vincristine; D003520:Cyclophosphamide; D010440:Peptichemio; D008558:Melphalan; D011241:Prednisone